Delphi Management Partners VIII »

Tandem Diabetes Care shares owned by Delphi Management Partners VIII

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by Delphi Management Partners VIII from 13F filings

Historical chart of Delphi Management Partners VIII investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Delphi Management Partners VIII consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Delphi Management Partners VIII

Quarter filed Position value Share count Share price at filing
2021-09-30 $119M 1.0M 119.38
2021-06-30 $97M 1.0M 97.40
2021-03-31 $88M 1.0M 88.25
2020-12-31 $96M 1.0M 95.68
2019-12-31 $60M 1.0M 59.61

More positions owned by Delphi Management Partners VIII

Tandem Diabetes Common Stock (TNDM)
Karyopharm Therapeutics Common Stock (KPTI)
Calithera Biosciences Common Stock
Mereo BioPharma Group Ads (MREO)

View all positions for Delphi Management Partners VIII

Top funds holding Tandem Diabetes Care

Vanguard Group
Arrowpoint Asset Management
Henderson Group
Bellevue Group
Jacobs Levy Equity Management
Jennison Associates
Jennifer Ranahan
Paradice Investment Management
Two Sigma Advisers
Point72 Asset Management
Voloridge Investment Management
Two Sigma Investments
Chicago Capital
Millennium Management
Squarepoint Ops

View all funds holding Tandem Diabetes Care